Landscapes / Companies
Zenas BioPharma (USA), LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 5 in all
Trials
6 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Bruton's tyrosine kinase inhibitor |
Beijing InnoCare Pharma Tech |
Approved in China | Jun 2030Phase 3 trial completes | ||
| How it works | Blocks BTK | ||||
| Next date | Jun 2030 · Phase 3 trial completes | ||||
| Also tested for | Multiple Sclerosis (MS) Primary Progressive, Secondary Progressive Multiple Sclerosis | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 3 | — | |||
| How it works | An antibody | ||||
| Also tested for | IgG4 Related Disease, Warm Autoimmune Hemolytic Anemia and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021